Your browser doesn't support javascript.
loading
[Eye and Behçet's disease]. / Œil et maladie de Behçet.
Ksiaa, I; Abroug, N; Kechida, M; Zina, S; Jelliti, B; Khochtali, S; Attia, S; Khairallah, M.
Afiliación
  • Ksiaa I; Service d'ophtalmologie, faculté de médecine, hôpital universitaire Fattouma Bourguiba, université de Monastir, Monastir, Tunisie.
  • Abroug N; Service d'ophtalmologie, faculté de médecine, hôpital universitaire Fattouma Bourguiba, université de Monastir, Monastir, Tunisie.
  • Kechida M; Service de médecine interne, faculté de médecine, hôpital universitaire Fattouma Bourguiba, université de Monastir, Monastir, Tunisie.
  • Zina S; Service d'ophtalmologie, faculté de médecine, hôpital universitaire Fattouma Bourguiba, université de Monastir, Monastir, Tunisie.
  • Jelliti B; Service d'ophtalmologie, faculté de médecine, hôpital universitaire Fattouma Bourguiba, université de Monastir, Monastir, Tunisie.
  • Khochtali S; Service d'ophtalmologie, faculté de médecine, hôpital universitaire Fattouma Bourguiba, université de Monastir, Monastir, Tunisie.
  • Attia S; Service d'ophtalmologie, faculté de médecine, hôpital universitaire Fattouma Bourguiba, université de Monastir, Monastir, Tunisie.
  • Khairallah M; Service d'ophtalmologie, faculté de médecine, hôpital universitaire Fattouma Bourguiba, université de Monastir, Monastir, Tunisie. Electronic address: moncef.khairallah@yahoo.fr.
J Fr Ophtalmol ; 42(6): 626-641, 2019 Jun.
Article en Fr | MEDLINE | ID: mdl-31164292
ABSTRACT
Behçet's disease is a chronic multisystem disorder characterized by relapsing inflammation for which the underlying histopathology is an occlusive vasculitis. The disease has a high prevalence in the Mediterranean region, Far and Middle Eastern countries. It is clinically characterized by oral and genital ulcerations, ocular inflammatory involvement, skin lesions, vascular involvement and numerous other systemic manifestations. Uveitis is by far the most common ocular manifestation of Behçet's disease. It typically presents in the form of relapsing-remitting panuveitis with retinal vasculitis that may result in severe visual loss. Management of Behçet's uveitis relies on corticosteroid therapy, conventional immunosuppressive drugs and biological agents and requires a close collaboration between ophthalmologist and internist. A better understanding of the auto-inflammatory process and of the role of cytokines implicated in the pathogenesis of Behçet's disease will enable researchers to develop more specific and effective therapy.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Uveítis / Síndrome de Behçet Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Adult / Humans Idioma: Fr Revista: J Fr Ophtalmol Año: 2019 Tipo del documento: Article País de afiliación: Túnez

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Uveítis / Síndrome de Behçet Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Adult / Humans Idioma: Fr Revista: J Fr Ophtalmol Año: 2019 Tipo del documento: Article País de afiliación: Túnez